Pathophysiology and Biomarkers for Breast Cancer: Management Using Herbal Medicines

被引:3
作者
Sharma, Disha [1 ]
Mishra, Sudhanshu [2 ]
Rajput, Aishwarya [2 ]
Raj, Khushboo [3 ]
Malviya, Rishabha [4 ]
机构
[1] Dr MC Saxena Coll Pharm, Lucknow, Uttar Pradesh, India
[2] Rajeev Gandhi Prodygiki Viswavidlaya, Sch Pharmaceut Sci, Bhopal, India
[3] Arka Jain Univ, Sch Pharm, Jamshedpur, Jharkhand, India
[4] Galgotias Univ, Sch Med & Allied Sci, Dept Pharm, Greater Noida, India
关键词
Cancer; breast cancer; carcinomas; biomarkers; herbal treatment; natural medicines; ALTERNATIVE MEDICINE; PROGNOSTIC MODEL; PHYLLODES TUMOR; INHIBITOR PAI-1; 5; CONTINENTS; RISK-FACTORS; IN-VIVO; DIAGNOSIS; THERAPY; EPIDEMIOLOGY;
D O I
10.2174/1573401317666210713114216
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Aims: The objective of the current manuscript is to discuss various types of cancers of breast, pathophysiology, and biomarkers used for breast cancer and potential applications of herbal remedies as a treatment tool. Methods: A literature survey was carried out using various online search engines like google scholar, ScienceDirect, Springer, Scopus, PubMed, etc. Offline libraries were also used for the compilation of data. Results and Discussion: The second ground for disease casualties in females is breast cancer. The complexity of this disorder resembles a complicated environment containing varying layers of internal and external influences that are cleverly engineered for interaction to create a pliable background for the clonal progress of breast cancer cells. Biomarkers which can identify the most successful treatments or assess the reaction to therapy early in the process of treatment are useful. The possible benefits of imaging biomarkers are evident and initial clinical results have been positive. Herbal medicines must be established to be successful against this disease. Conclusion: It can be established from the complete study that breast cancer is mainly universal and lethal cancer of females. Herbal medicines are widely distributed, biocompatible, biodegradable, and have the potential to treat breast cancer. Furthermore, multicenter clinical trials are still needed for evidence of the clinical usefulness of herbal medicines.
引用
收藏
页码:974 / 984
页数:11
相关论文
共 93 条
[1]   Awareness and current knowledge of breast cancer [J].
Akram, Muhammad ;
Iqbal, Mehwish ;
Daniyal, Muhammad ;
Khan, Asmat Ullah .
BIOLOGICAL RESEARCH, 2017, 50
[2]  
Al-Brahim N, 2006, ARCH PATHOL LAB MED, V130, P1057
[3]  
Alkabban FM., 2020, Breast Cancer
[4]   Molecular Pathology of Breast Cancer What a Pathologist Needs to Know [J].
Allison, Kimberly H. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (06) :770-780
[5]  
Anderson William F, 2005, Breast Dis, V22, P9
[6]  
[Anonymous], 2008, Imaginis
[7]  
[Anonymous], 2007, ONCOL TIMES, V29, P8, DOI [10.1097/01.COT.0000267748.71667.2d, DOI 10.1097/01.COT.0000267748.71667.2D]
[8]   Molecular biomarkers for breast cancer prognosis: Coexpression of c-erbB-2 and p53 [J].
Beenken, SW ;
Grizzle, WE ;
Crowe, DR ;
Conner, MG ;
Weiss, HL ;
Sellers, MT ;
Krontiras, H ;
Urist, MM ;
Bland, KI .
ANNALS OF SURGERY, 2001, 233 (05) :630-637
[9]   Luminal-B breast cancer and novel therapeutic targets [J].
Ben Tran ;
Bedard, Philippe L. .
BREAST CANCER RESEARCH, 2011, 13 (06)
[10]   Differences Between Older and Younger Cancer Survivors in Seeking Cancer Information and Using Complementary/Alternative Medicine [J].
Bennett, Jill A. ;
Cameron, Linda D. ;
Whitehead, Lisa C. ;
Porter, David .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 (10) :1089-1094